The estimation of acute pancreatitis incidence in children with inflammatory bowel disease;Ocena czȩstości wystȩpowania ostrego zapalenia trzustki w przebiegu przewlekłych nieswoistych zapaleń jelit u dzieci

Polski Merkuriusz Lekarski

Volumn 16, Issue 97, 2004, Pages 33-36

  Stawarski, Andrzej ^a   Iwańczak, Franciszek ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Acute pancreatitis; Children; Crohn's disease; Ulcerative colitis

Indexed keywords

AMYLASE; AZATHIOPRINE; BUDESONIDE; MESALAZINE; PREDNISONE; SALAZOSULFAPYRIDINE; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; ADOLESCENT; ADULT; ARTICLE; CHILD; COMORBIDITY; CORRELATION FUNCTION; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; ULCERATIVE COLITIS; URINE LEVEL; ACUTE DISEASE; BLOOD; ENZYMOLOGY; PANCREATITIS; POLAND; PRESCHOOL CHILD; RETROSPECTIVE STUDY; URINE;

ACUTE DISEASE; ADOLESCENT; AMYLASES; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; LIPASE; MALE; PANCREATITIS; POLAND; RETROSPECTIVE STUDIES;

EID: 16644400320     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Uretsky G., Goldschmiedt M., James K.: Childhood pancreatitis. Am. Family Phys., 1999, 59, 9, 2507-12.
2. Iwańczak F.: Najczȩstsze przyczyny chorób trzustki u dzieci. Nowa Pediatria, 2002, 30, 3, 159-62.
3. Meuwissen S.G., Ewe K., Gassull M.A. i wsp.: IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol., 2000, 12, 1, 13-18.
4. Rasmussen H.H., Fonager K., Sorensen H.T. i wsp.: Risk of acute pancreatitis in patients with chronic inflammatory bowel disease. A Danish 16-year nationwide follow-up study. Scand. J. Gastroenterol., 1999, 34, 2, 199-201.
5. Levine J.B., Lukawski-Trubish D.: Extraintestinal considerations in inflammatory bowel disease. Gastroenterol. Clin. North Am., 1995, 24, 3, 633-646.
6. Sunamura M., Lozonschi L., Takeda K. i wsp.: Criteria for diagnosis of acute pancreatitis in Japan and clinical implications. Pancreas, 1998, 16, 3, 243-249.
7. Levine J.B., Lukawski-Trubish D.: Extraintestinal considerations in inflammatory bowel disease. Gastroenterol. Clin. North Am., 1995, 24, 3, 633-646.
8. Heikius B., Niemela S., Lehtola J. i wsp.: Elevated pancreatic enzymes in inflammatory bowel disease are associated with extensive disease. Am. J. Gastroenterol., 1999, 94, 4, 1062-69.
9. Le Large-Guiheneuf C., Hugot J.P., Faure C. i wsp.: Pancreatic involvement in inflammatory bowel disease in children. Arch. Pediatr., 2002, 9, 5, 469-477,
10. Stawarski A.: Polekowe zapalenie trzustki. Gastroenterol. Pol., 2001, 2001, 8, 79-85.
11. Kader H.A., Mascarenhas M.R., Piccoli D.A. i wsp.: Experiences with 6-mercaptopurine and azathiporine therapy in pediatric patients with severe ulcerative colitis. J. Pediatr. Gastroenterol. Nutr., 1999, 28, 1, 54-58.
12. Kirschner B.S.: Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflamatory bowel disease. Gastroenterology, 1998, 115, 4, 813-821.
13. Ransford R.A., Langman M.J.: Sulphasalazine and mesalazine: serious adverse reactions reevaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut, 2002, 51, 4, 536-539.
14. Barthet M., Hastier P., Bernard J.P. i wsp.: Chronic pancreatitis and inflammatory bowel disease: true or coincidental association? Am. J. Gastroenterol., 1999, 94, 8, 2141-48.
15. Conwell D.L., Lashner B.A.: For pancreatitis in inflammatory bowel disease, treat the bowel. Am. J. Gastroenterol., 1999, 94, 8, 2001.